International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
Mehta, Ravindra L, Prof, Cerdá, Jorge, Prof, Burdmann, Emmanuel A, Prof, Tonelli, Marcello, Prof, García-García, Guillermo, Prof, Jha, Vivekanand, Prof, Susantitaphong, Paweena, MD, Rocco, Michael, Prof, Vanholder, Raymond, Prof, Sever, Mehmet Sukru, Prof, Cruz, Dinna, MD, Jaber, Bertrand, Prof, Lameire, Norbert H, Prof, Lombardi, Raúl, Prof, Lewington, Andrew, MD, Feehally, John, Prof, Finkelstein, Fredric, Prof, Levin, Nathan, Prof, Pannu, Neesh, MD, Thomas, Bernadette, MD, Aronoff-Spencer, Eliah, MD, Remuzzi, Giuseppe, Prof
Published in The Lancet (British edition) (27.06.2015)
Published in The Lancet (British edition) (27.06.2015)
Get full text
Journal Article
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study
Mehta, Ravindra L, Prof, Burdmann, Emmanuel A, Prof, Cerdá, Jorge, Prof, Feehally, John, Prof, Finkelstein, Fredric, Prof, García-García, Guillermo, Prof, Godin, Melanie, MD, Jha, Vivekanand, MD, Lameire, Norbert H, Prof, Levin, Nathan W, Prof, Lewington, Andrew, MD, Lombardi, Raúl, MD, Macedo, Etienne, MD, Rocco, Michael, Prof, Aronoff-Spencer, Eliah, MD, Tonelli, Marcello, Prof, Zhang, Jing, MAS, Remuzzi, Giuseppe, Prof
Published in The Lancet (British edition) (14.05.2016)
Published in The Lancet (British edition) (14.05.2016)
Get full text
Journal Article
Chronic kidney disease: global dimension and perspectives
Jha, Vivekanand, Prof, Garcia-Garcia, Guillermo, Prof, Iseki, Kunitoshi, Prof, Li, Zuo, MD, Naicker, Saraladevi, Prof, Plattner, Brett, MD, Saran, Rajiv, Prof, Wang, Angela Yee-Moon, Prof, Yang, Chih-Wei, Prof
Published in The Lancet (British edition) (20.07.2013)
Published in The Lancet (British edition) (20.07.2013)
Get full text
Journal Article
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
Takahashi, Koichi, MD, Wang, Feng, PhD, Kantarjian, Hagop, Prof, Doss, Denaha, MS, Khanna, Kanhav, MS, Thompson, Erika, MS, Zhao, Li, PhD, Patel, Keyur, MD, Neelapu, Sattva, MD, Gumbs, Curtis, BS, Bueso-Ramos, Carlos, Prof, DiNardo, Courtney D, MD, Colla, Simona, PhD, Ravandi, Farhad, Prof, Zhang, Jianhua, PhD, Huang, Xuelin, PhD, Wu, Xifeng, Prof, Samaniego, Felipe, MD, Garcia-Manero, Guillermo, Prof, Futreal, P Andrew, Prof
Published in The lancet oncology (2017)
Published in The lancet oncology (2017)
Get full text
Journal Article
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
Jabbour, Elias, Dr, Kantarjian, Hagop, Prof, Ravandi, Farhad, Prof, Thomas, Deborah, Prof, Huang, Xuelin, Prof, Faderl, Stefan, Prof, Pemmaraju, Naveen, Prof, Daver, Naval, MD, Garcia-Manero, Guillermo, Prof, Sasaki, Koji, MD, Cortes, Jorge, Prof, Garris, Rebecca, Yin, C Cameron, MD, Khoury, Joseph D, MD, Jorgensen, Jeffrey, Prof, Estrov, Zeev, Prof, Bohannan, Zachary, MA, Konopleva, Marina, MD, Kadia, Tapan, MD, Jain, Nitin, MD, DiNardo, Courtney, MD, Wierda, William, Prof, Jeanis, Vicky, RN, O'Brien, Susan, Prof
Published in The lancet oncology (01.11.2015)
Published in The lancet oncology (01.11.2015)
Get full text
Journal Article
Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study
Kantarjian, Hagop, Prof, Faderl, Stefan, Prof, Garcia-Manero, Guillermo, Prof, Luger, Selina, Prof, Venugopal, Parameswaran, Prof, Maness, Lori, MD, Wetzler, Meir, Prof, Coutre, Steven, MD, Stock, Wendy, Prof, Claxton, David, Prof, Goldberg, Stuart L, Prof, Arellano, Martha, MD, Strickland, Stephen A, MD, Seiter, Karen, Prof, Schiller, Gary, Prof, Jabbour, Elias, MD, Chiao, Judy, MD, Plunkett, William, Prof
Published in The lancet oncology (01.11.2012)
Published in The lancet oncology (01.11.2012)
Get full text
Journal Article
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
Garcia-Manero, Guillermo, Dr Prof, Fenaux, Pierre, Prof, Al-Kali, Aref, MD, Baer, Maria R, Prof, Sekeres, Mikkael A, Prof, Roboz, Gail J, Prof, Gaidano, Gianluca, Prof, Scott, Bart L, MD, Greenberg, Peter, Prof, Platzbecker, Uwe, Prof, Steensma, David P, MD, Kambhampati, Suman, MD, Kreuzer, Karl-Anton, Prof, Godley, Lucy A, Prof, Atallah, Ehab, MD, Collins, Robert, Prof, Kantarjian, Hagop, Prof, Jabbour, Elias, MD, Wilhelm, Francois E, MD, Azarnia, Nozar, PhD, Silverman, Lewis R, MD
Published in The lancet oncology (01.04.2016)
Published in The lancet oncology (01.04.2016)
Get full text
Journal Article
Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study
DiNardo, Courtney D, Daver, Naval, Jabbour, Elias, Kadia, Tapan, Borthakur, Gautam, Konopleva, Marina, Pemmaraju, Naveen, Yang, Hui, Pierce, Sherry, Wierda, William, Bueso-Ramos, Carlos, Patel, Keyur P, Cortes, Jorge E, Ravandi, Farhad, Kantarjian, Hagop M, Garcia-Manero, Guillermo
Published in The Lancet. Haematology (01.01.2015)
Published in The Lancet. Haematology (01.01.2015)
Get more information
Journal Article